NHS approval of endometriosis therapy Ryeqo enhances patient care, eases healthcare strain, says GlobalData. A new endometriosis pill, relugolix combination therapy (Ryeqo), has been approved for NHS use in England. Expected to benefit around 1,000 women annually, the pill offers a more convenient, effective treatment option. The National Health Service (NHS) in England has approved […]
Read More… from NHS approval of endometriosis therapy Ryeqo enhances patient care